Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12Gynecologic 4Sarcoma 2Thoracic 1Lymphoid 1

Conditions

Lymphoma, Follicular 1Coma 1Cerebrovascular Disorders 1Brain Injuries, Traumatic 1

Interventions

Rituximab 1371Cyclophosphamide 1297Vincristine 662Doxorubicin 583Etoposide 525Prednisone 505Cytarabine 481fludarabine 462Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 255ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 228Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Enhanced Recovery After Surgery × Lymphoid × Clear all
NCT06241482 2025-03-04

Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care

Shanghai 6th People's Hospital

Phase NA Recruiting
80 enrolled
Lymphoid

Brain Injuries, Traumatic, Cerebrovascular Disorders, Coma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡